Remaining shareholders who did not tender should promptly submit their shares to receive the $124.00 per share merger consideration. The stock will be delisted and deregistered, eliminating any further public trading. No remaining catalyst for the common equity.
Price Chart
Executive Summary
GSK plc has completed its acquisition of Nuvalent, Inc. via a tender offer and merger. The tender offer expired with 91.3% of shares tendered, and the merger closed on July 15, 2026, at $124.00 per share in cash, representing a total equity value of approximately $10.6 billion. All outstanding shares, options, and RSUs were cashed out, and the company will be delisted from Nasdaq.
Key Facts
- Tender offer expired on July 14, 2026 with 72,518,967 shares (91.3% of outstanding) validly tendered
- Merger closed on July 15, 2026 under DGCL Section 251(h) without a stockholder vote
- Shareholders received $124.00 per share in cash, less applicable withholding
- Total equity value of the transaction approximately $10.6 billion
- All outstanding stock options and RSUs were cancelled and converted to cash at the Offer Price
- Nasdaq trading halted after market close on July 14, 2026; delisting and deregistration initiated
- All incumbent directors and officers resigned; replaced by appointees of GSK's acquisition subsidiary
- Certificate of incorporation and bylaws were amended and restated
Financial Impact
Transaction valued at approximately $10.6 billion in total equity value, with all outstanding shares converted to $124.00 cash per share. No ongoing public equity or financial reporting.
Risk Factors
- Shareholders who do not tender or demand appraisal rights may face delays in receiving cash
- Delisting and deregistration eliminate liquidity and public market access
- Potential appraisal litigation if shareholders believe the price was inadequate
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-304126 |
| Document: d52896d8k.htm | 0001193125-26-304126 |
| Document: d52896dex31.htm | 0001193125-26-304126 |
| Document: 0001193125-26-304126-index-headers.html | 0001193125-26-304126 |
| Document: 0001193125-26-304126-index.html | 0001193125-26-304126 |
| Document: 0001193125-26-304126.txt | 0001193125-26-304126 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 9w ago | 15-12G | — | awaiting T+5 | — | — |
Jul 15, 2026 11w ago | 25-NSE | $123.96 $123.96 | · 0.00% | ▲ +0.98% | — |
Jul 15, 2026 11w ago | 8-K | $123.96 $123.96 | · 0.00% | ▲ +0.98% | — |
Jul 8, 2026 12w ago | Insider Cluster | $123.80 $123.96 | ▲ +0.13% | ▼ −0.73% | — |
Jul 6, 2026 12w ago | Insider Cluster | $123.72 $123.90 | ▲ +0.15% | ▼ −0.34% | — |
Jun 11, 2026 16w ago | Insider Cluster | $123.25 $123.43 | ▲ +0.15% | ▼ −0.53% | — |
Jun 10, 2026 16w ago | Insider Cluster | $123.45 $123.36 | ▼ −0.07% | ▼ −0.51% | — |
Jun 9, 2026 16w ago | 8-K | $123.25 $123.35 | ▲ +0.08% | ▼ −2.33% | — |
May 7, 2026 21w ago | 8-K | $102.40 $105.22 | ▲ +2.75% | ▲ +1.25% | — |
Apr 29, 2026 22w ago | Insider Cluster | $99.10 $101.47 | ▲ +2.39% | ▼ −0.72% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access